Incidence of diabetes in children and adolescents during the COVID-19 pandemic: a systematic review and meta-analysis

D D'Souza, J Empringham, P Pechlivanoglou… - JAMA Network …, 2023 - jamanetwork.com
Importance There are reports of increasing incidence of pediatric diabetes since the onset of
the COVID-19 pandemic. Given the limitations of individual studies that examine this …

Type 1 diabetes

T Quattrin, LD Mastrandrea, LSK Walker - The Lancet, 2023 - thelancet.com
Type 1 diabetes is a chronic disease caused by autoimmune destruction of pancreatic β
cells. Individuals with type 1 diabetes are reliant on insulin for survival. Despite enhanced …

[PDF][PDF] ISPAD Clinical Practice Consensus Guidelines 2022: Definition, epidemiology, and classification of diabetes in children and adolescents

I Libman, A Haynes, S Lyons, P Pradeep… - Pediatric …, 2022 - digibete.org
This chapter serves as an update and replaces the 2018 ISPAD consensus guideline on
definition, epidemiology, and classification of diabetes in children and adolescents. 1 It …

Enteroviruses and risk of islet autoimmunity or type 1 diabetes: systematic review and meta-analysis of controlled observational studies detecting viral nucleic acids …

SR Isaacs, A Roy, B Dance, EJ Ward… - The Lancet Diabetes & …, 2023 - thelancet.com
Background Enteroviruses are routinely detected with molecular methods within large
cohorts that are at risk of type 1 diabetes. We aimed to examine the association between …

2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024

Diabetes Care, 2024 - Am Diabetes Assoc
The American Diabetes Association (ADA)“Standards of Care in Diabetes” includes the
ADA's current clinical practice recommendations and is intended to provide the components …

Estimating the total incidence of type 1 diabetes in children and adolescents aged 0–19 years from 1990 to 2050: a global simulation-based analysis

ZJ Ward, JM Yeh, CL Reddy, A Gomber… - The lancet Diabetes & …, 2022 - thelancet.com
Background Previous studies of type 1 diabetes in childhood and adolescence have found
large variations in reported incidence around the world. However, it is unclear whether these …

The role of structural racism and geographical inequity in diabetes outcomes

S Agarwal, AN Wade, JC Mbanya, C Yajnik, N Thomas… - The Lancet, 2023 - thelancet.com
Diabetes is pervasive, exponentially growing in prevalence, and outpacing most diseases
globally. In this Series paper, we use new theoretical frameworks and a narrative review of …

SGLT2i and GLP-1 RA therapy in type 1 diabetes and reno-vascular outcomes: a real-world study

M Anson, SS Zhao, P Austin, GH Ibarburu, RA Malik… - Diabetologia, 2023 - Springer
Aims/hypothesis Insulin is the primary treatment for type 1 diabetes. However, alternative
glucose-lowering therapies are used adjunctively, but importantly are off-label in type 1 …

Real‐world performance of the MiniMed 780G advanced hybrid closed loop system in Latin America: substantial improvement in glycaemic control with each …

B Grassi, AM Gómez, LE Calliari… - Diabetes, Obesity …, 2023 - Wiley Online Library
Aim We studied real‐world performance of MiniMed (MM) 780G system users from
Argentina, Brazil, Colombia and Chile (geographical analysis), and the effect of each …

Umbilical cord-derived mesenchymal stromal cells preserve endogenous insulin production in type 1 diabetes: a phase I/II randomised double-blind placebo …

PO Carlsson, D Espes, S Sisay, LC Davies, CIE Smith… - Diabetologia, 2023 - Springer
Aim/hypothesis This study aimed to investigate the safety and efficacy of treatment with
allogeneic Wharton's jelly-derived mesenchymal stromal cells (MSCs) in recent-onset type 1 …